Want to keep track of the largest startup funding deals in 2025 with our curated list of $100 million-plus venture deals to U.S.-based companies? Check out The Crunchbase Megadeals Board.
This is a weekly feature that runs down the week’s top 10 announced funding rounds in the U.S. Check out the biggest funding rounds of last week here.
The past few weeks were slow when it came to big rounds, but this week was quite the bounce-back. More than a half dozen startups raised $100 million or more, as investors went big on robotics and legal tech.
1. Apptronik, $350M, robotics: Although robotics funding remained relatively unchanged last year, some humanoid robot startups certainly have seen massive cash from investors. Add Apptronik to that list, as the Austin, Texas-based AI-powered humanoid robotics company locked up a $350 million Series A co-led by B Capital and Capital Factory, with participation from Google. Founded in 2016, Apptronik had previously raised $28 million, per the company. The robotics startup will use the fresh cash to develop its humanoid robot designed for industrial work, Apollo. The company, which competes with Tesla, has partnered with NASA and Nvidia, and has developed 15 robotic systems, including NASA’s humanoid robot Valkyrie.
2. Harvey, $300M, legal: It was just seven months ago San Francisco-based artificial intelligence legal tech startup Harvey made this list after it raised a $100 million Series C led by GV with participation from the likes of OpenAI, Kleiner Perkins and Sequoia Capital at a $1.5 billion valuation. It’s back again with a $300 million round led by Sequoia that values the startup at $3 billion, per a report. Harvey develops AI tools that help legal pros with research, document review and contract analysis. Founded in 2022, the company has raised $506 million, per Crunchbase.
3. QuEra Computing, $230M, quantum: Everyone wants to know when quantum computing will seemingly become a real thing. That has not stopped investors from putting more cash into quantum-related startups. This week SoftBank’s Vision Fund unit and Google Quantum AI both took part in a whopping $230 million round for Boston-based neutral-atom quantum firm QuEra Computing. Neutral-atom quantum computing has lower error rates than other quantum systems. Founded in 2018, the company has raised $247 million, per Crunchbase.
4. Abcuro, $200M, biotech: The big biotech raise of the week (there seems to always be one) went to Newton, Massachusetts-based Abcuro. The startup, which is developing therapies for the treatment of autoimmune diseases and cancer through cytotoxic T cells, closed a $200 million Series C led by New Enterprise Associates. Founded in 2015, the company has raised nearly $415 million, per Crunchbase.
5. Chestnut Carbon, $160M, climate: Climate tech has been slow recently. But that did not stop Chestnut Carbon from locking up a $160 million Series B from several investors, including existing investor Canada Pension Plan Investment Board. The New York-based startup develops new forests on marginal crop and pasture lands, granting verified carbon credits to its corporations. Founded in 2021, the company has raised $360 million, per Crunchbase.
6. K2 Space, $110M, space: Torrence, California-based K2 Space, a satellite platform developer, locked up a $110 million Series B co-led by Altimeter Capital and Lightspeed Venture Partners. Founded in 2022, K2 has raised $180 million, per the company.
7. Eudia, $105M, legal: Palo Alto, California-based Eudia, an AI legal tech startup, closed a $105 million Series A led by General Catalyst as it came out of stealth.
8. EnCharge AI, $100M, semiconductor: With AI being all the rage, chips seem to be the talk of tech right now. EnCharge AI, a startup developing analog in-memory-computing AI chips, raised a Series B of more than $100 million led by Tiger Global. Founded in 2022, EnCharge has raised more than $144 million, per the company.
9. Newleos Therapeutics, $94M, biotech: Boston-based Newleos Therapeutics, a biotech startup developing multiple treatments for anxiety, social anxiety, substance use disorders and cognitive impairment, locked up a $93.5 million Series A led by Goldman Sachs Alternatives. This is the company’s first announced round, per Crunchbase.
10. Bambusa Therapeutics, $90M, biotech: Boston-based Bambusa Therapeutics, a biotech startup developing bispecific antibodies for immunological and inflammatory disorders, raised a $90 million Series A led by new investor RA Capital Management. Founded in 2024, the company has raised $105 million, per Crunchbase.
The largest deal of the week outside the U.S. came from the Middle East.
We tracked the largest announced rounds in the Crunchbase database that were raised by U.S.-based companies for the seven-day period of Feb. 8 to Feb. 14. Although most announced rounds are represented in the database, there could be a small time lag as some rounds are reported late in the week.
Stay up to date with recent funding rounds, acquisitions, and more with the
Crunchbase Daily.
